| | |
S. pneumoniae
|
H. influenzae
|
Biofilm production by either S. pneumoniae or H. influenzae isolated together
|
|---|
| |
Biofilm production by S. pneumoniae Total
|
Biofilm production by S. pneumoniae isolated alone
|
Biofilm production by S. pneumoniae isolated with H. influenzae
|
Biofilm production by H. influenzae isolated with S. pneumoniae
|
|---|
| | | |
S. pneumoniae Total
|
S. pneumoniae Biofilm+
|
S. pneumoniae Biofilm -
| | |
|---|
|
Serotype (n)
|
n (%)
|
n (%)
|
Biofilm + n (%)
|
Hi Biofilm +
|
Hi Biofilm -
|
Hi Biofilm +
|
Hi Biofilm -
|
n (%)
|
n (%)
|
|---|
|
PCV7
|
|
6B (11)
|
10 (91)
|
7/8 (88)
|
3/3 (100)
|
1
|
2
| | |
1/3(33)
|
3/3 (100)
|
|
9 V (2)
|
2 (100)
|
1/1 (100)
|
1/1 (100)
|
1
| | | |
1/1 (100)
|
1/1 (100)
|
|
14 (10)
|
6(60)
|
1/2 (50)
|
5/8 (63)
|
5
| |
3
| |
8/8 (100)
|
8/8 (100)
|
|
18C (1)
|
1 (100)
|
0
|
1/1 (100)
|
1
| | | |
1/1 (100)
|
1/1 (100)
|
|
19F (17)
|
7 (41)
|
2/6 (33)
|
5/11 (45)
|
4
|
1
|
4
|
2
|
8/11 (73)
|
9/11 (82)
|
|
23F (13)
|
5 (38)
|
3 /7(43)
|
2/5 (40)
|
1
|
1
|
2
|
1
|
3/5 (60)
|
4/5 (80)
|
|
Total
|
31/54 (57.4)
|
14/24 (58.3)
|
17/29 (58.6)
|
13
|
4
|
9
|
3
|
22/29 (75.9)
|
26/29 (89.9)
|
|
PCV13 additional serotypes
|
|
1 (1)
|
0
|
0
|
0/1
| | |
1
| |
1/1 (100)
|
1/1(100)
|
|
3 (1)
|
0
|
0/1
|
0/0
| | | | |
0
|
0
|
|
5 (1)
|
1 (100)
|
0
|
1/1 (100)
| |
1
| | |
0/1
|
1/1 (100)
|
|
6A (6)
|
3 (50)
|
2/5 (40)
|
1/1 (100)
|
1
| | | |
1/1(100)
|
1/1 (100)
|
|
7F (2)
|
2 (100)
|
1/1 (100)
|
1/1 (100)
|
1
| | | |
1/1(100)
|
1/1 (100)
|
|
19A (17)
|
16 (94)
|
8/8 (100)
|
8/9 (89)
|
6
|
2
|
1
| |
7/9 (78)
|
9/9 (100)
|
|
Total
|
22/28 (78.5)
|
11/15 (73.3)
|
11/13(84)
|
8
|
3
|
2
| |
10/13 (77)
|
13/13 (100)
|
|
Other serotypes
|
|
15B/C (15)
|
14 (93)
|
8/8 (100)
|
6/7 (86)
|
4
|
2
| |
1
|
4/7 (57)
|
6/7 (86)
|
|
15A (12)
|
6 (50)
|
3/5 (60)
|
3/7 (43)
|
3
| |
4
| |
7/7 (100)
|
7/7 (100)
|
|
11A (9)
|
6 (67)
|
3/3 (100)
|
3/6 (50)
|
3
| |
2
|
1
|
5/6 (83)
|
5/6 (83)
|
|
23B (9)
|
3 (33)
|
0/4
|
3/5 (60)
|
3
| |
2
| |
5/5 (100)
|
5/5 (100)
|
|
23A (12)
|
8 (67)
|
6/8 (75)
|
2/4 (50)
|
1
|
1
|
2
| |
2/3 (67)
|
4/4 (100)
|
|
10A (6)
|
3 (50)
|
0/2
|
3/4 (75)
|
1
|
2
|
1
| |
2/3 (67)
|
4/4 (100)
|
|
21 (5)
|
2 (40)
|
1/2 (50)
|
1/3 (33)
| |
1
|
2
| |
2/3(67)
|
3/3 (100)
|
|
35F (4)
|
4 (100)
|
1/1 (100)
|
3/3 (100)
|
2
|
1
| | |
2/3 (67)
|
3/3 (100)
|
|
35B (6)
|
5 (83)
|
3/4 (75)
|
2/2 (100)
| |
2
| | |
0/2
|
2/2 (100)
|
|
6C (4)
|
2 (50)
|
1/2 (50)
|
1/2 (50)
|
1
| |
1
| |
2/2 (100)
|
2/2 (100)
|
|
17F (4)
|
4 (100)
|
3/3 (100)
|
1/1 (100)
|
1
| | | |
1/1(100)
|
1/1 (100)
|
|
22F(2), 29(2)
|
2 (50)
|
0/2
|
2/2 (100)
|
1
| | | |
2/2 (100)
|
2/2(100)
|
|
24F (2)
|
1 (50)
|
1/1 (100)
|
0/1
| | | |
1
|
0/1
|
0
|
|
15F (1)
|
0 (0)
|
0/1 (0)
|
0/1
| | |
1
| |
1/1 (100)
|
1/1 (100)
|
|
16(1)
|
1 (100)
|
0
|
1/1 (100)
|
1
| | | |
1/1 (100)
|
1/1 (100)
|
|
38 (1)
|
1 (100)
|
0
|
1/1 (100)
| |
1
| | |
0/1
|
1/ 1(100)
|
|
8(2), 12F (1), 25A (1) 31 (1), 33F (1)
|
5 (83.3)
|
5/6 (83.3)
|
0/0
| | | | |
0
|
0
|
|
Total
|
67/101 (69.3)
|
43/62 (69.3)
|
36/57 (63.1)
|
24
|
11
|
17
|
4
|
36/48 (75)
|
46/48 (94.6)
|
|
NT (7)
|
7 (100)
|
3/3(100)
|
4/4 (100)
|
3
|
1
| | |
3/4 (75)
|
4/4 (100)
|
|
Total
|
127/190 (66.8%)
|
64/95 (67.4%)
|
64/97 (66%)
|
46/65 (71%)
|
18/65 (27.6%)
|
26/32 (81.2%)
|
6/32 (18.7%)
|
71/94 (75.5%)
|
89/94 (94.6%)
|
- PCV7: Serotypes included in the PCV7 vaccin
- PCV13 additionnal serotypes: Additionnal serotypes added in the PCV13 vaccin
- NT: non typable serotypes
